94 related articles for article (PubMed ID: 19489220)
1. [Morphologic assessment of response to neoadjuvant chemotherapy in breast cancer].
Zheng S; Zhang BL; Zou SM; Lin DM; Xue LY; Luo W; Yuan YL; Lü N
Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):18-22. PubMed ID: 19489220
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of histopathologic changes and expression of biomarkers in breast carcinoma before and after neoadjuvant chemotherapy].
Zheng S; Zhang BL; Xiao T; Zou SM; Xue LY; Luo W; Guo L; Liu XY; Lü N
Zhonghua Bing Li Xue Za Zhi; 2011 Jul; 40(7):465-70. PubMed ID: 22088373
[TBL] [Abstract][Full Text] [Related]
3. [Differences between clinical response and pathologic response of breast cancer after neoadjuvant chemotherapy].
Zheng S; Zhang BL; Zhang RZ; Yang JL; Zou SM; Xue LY; Luo W; Yuan YL; Lü N
Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):734-8. PubMed ID: 21215162
[TBL] [Abstract][Full Text] [Related]
4. Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer.
Cho JH; Park JM; Park HS; Park S; Kim SI; Park BW
J Surg Oncol; 2013 Dec; 108(8):531-6. PubMed ID: 24115142
[TBL] [Abstract][Full Text] [Related]
5. Assessment of pathological response to neoadjuvant chemotherapy in locally advanced breast cancer using the Miller-Payne system and TUNEL.
Shintia C; Endang H; Diani K
Malays J Pathol; 2016 Apr; 38(1):25-32. PubMed ID: 27126661
[TBL] [Abstract][Full Text] [Related]
6. [Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer].
Ma WY; Zhang P; Zhang BL; Wang X; Xu XZ; Zheng S; Wang JY; Cai RG; Yuan P; Ma F; Fan Y; Xu BH
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):770-4. PubMed ID: 23291072
[TBL] [Abstract][Full Text] [Related]
7. Pathologic response and long-term follow-up in breast cancer patients treated with neoadjuvant chemotherapy: a comparison between classifications and their practical application.
Corben AD; Abi-Raad R; Popa I; Teo CH; Macklin EA; Koerner FC; Taghian AG; Brachtel EF
Arch Pathol Lab Med; 2013 Aug; 137(8):1074-82. PubMed ID: 23899063
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in operable breast cancer treated with neoadjuvant chemotherapy: towards a quantification of residual disease.
Mombelli S; Kwiatkowski F; Abrial C; Wang-Lopez Q; de Boissieu P; Garbar C; Bensussan A; Curé H
Oncology; 2015; 88(5):261-72. PubMed ID: 25573741
[TBL] [Abstract][Full Text] [Related]
9. Impact of preoperative evaluation of tumour grade by core needle biopsy on clinical risk assessment and patient selection for adjuvant systemic treatment in breast cancer.
Waaijer L; Willems SM; Verkooijen HM; Buck DB; van der Pol CC; van Diest PJ; Witkamp AJ
Br J Surg; 2015 Aug; 102(9):1048-55. PubMed ID: 26176340
[TBL] [Abstract][Full Text] [Related]
10. Isolate local failure after breast-conserving treatment for early breast cancer, about 57 cases.
Deniaud-Alexandre E; Lauratet B; Lefranc JP; Genestié C; Lerouge D; Moureau-Zabotto L; Touboul E
Cancer Radiother; 2004 Apr; 8(2):95-107. PubMed ID: 15063877
[TBL] [Abstract][Full Text] [Related]
11. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
12. Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy.
Yagata H; Kajiura Y; Yamauchi H
Breast Cancer; 2011 Jul; 18(3):165-73. PubMed ID: 21290263
[TBL] [Abstract][Full Text] [Related]
13. Correlation of clinico-pathologic and radiologic parameters of response to neoadjuvant chemotherapy in breast cancer.
Mukherjee P; Sharma S; Sheikh ZA; Vijaykumar DK
Indian J Cancer; 2014; 51(1):25-9. PubMed ID: 24947092
[TBL] [Abstract][Full Text] [Related]
14. Pathological controversies in breast cancer: classification of ductal carcinoma in situ, sentinel lymph nodes and low volume metastatic disease and reporting of neoadjuvant chemotherapy specimens.
Provenzano E; Brown JP; Pinder SE
Clin Oncol (R Coll Radiol); 2013 Feb; 25(2):80-92. PubMed ID: 23199579
[TBL] [Abstract][Full Text] [Related]
15. Surgical complications of skin sparing mastectomy and immediate prosthetic reconstruction after neoadjuvant chemotherapy for invasive breast cancer.
Donker M; Hage JJ; Woerdeman LA; Rutgers EJ; Sonke GS; Vrancken Peeters MJ
Eur J Surg Oncol; 2012 Jan; 38(1):25-30. PubMed ID: 21963981
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic value of core needle biopsy before neoadjuvant chemotherapy for breast cancer].
Zheng S; Zhang BL; Zou SM; Lin DM; Xue LY; Luo W; Lu N
Zhonghua Bing Li Xue Za Zhi; 2008 Feb; 37(2):99-102. PubMed ID: 18681320
[TBL] [Abstract][Full Text] [Related]
17. Clinical and pathological response to neoadjuvant chemotherapy based on primary tumor reduction is correlated to survival in hormone receptor-positive but not hormone receptor-negative locally advanced breast cancer.
Chen S; Liu Y; Ouyang QW; Huang L; Luo RC; Shao ZM
Ann Surg Oncol; 2015 Jan; 22(1):32-9. PubMed ID: 25012266
[TBL] [Abstract][Full Text] [Related]
18. Pathologic response to short intensified taxane-free neoadjuvant chemotherapy in patients with highly proliferative operable breast cancer.
Le Tourneau C; Dettwiler S; Beuzeboc P; Alran S; Laurence V; Pierga JY; Fréneaux P; Sigal-Zafrani B; Diéras V; Vincent-Salomon A
Am J Clin Oncol; 2012 Jun; 35(3):242-6. PubMed ID: 21358298
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy analysis of THP-containing regimens as neoadjuvant and adjuvant chemotherapy for primary breast cancer].
Wang LZ; Ouyang T; Wang TF; Xie YT; Fan ZQ; Fan T; Lin BY; Li JF
Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):143-6. PubMed ID: 22780935
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
